Enzon Pharmaceuticals (ENZN)
Enzon Pharmaceuticals Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 25, 2012 | 6.17 | 6.32 | 6.141 | 6.32 | 241388 |
| May 24, 2012 | 6.08 | 6.25 | 6.08 | 6.16 | 256677 |
| May 23, 2012 | 5.89 | 6.09 | 5.89 | 6.09 | 262350 |
| May 22, 2012 | 6.06 | 6.13 | 5.92 | 5.96 | 135534 |
| May 21, 2012 | 6.05 | 6.15 | 6.03 | 6.08 | 206947 |
| May 18, 2012 | 6.05 | 6.07 | 5.98 | 6.02 | 196335 |
| May 17, 2012 | 6.11 | 6.13 | 6.04 | 6.04 | 110052 |
| May 16, 2012 | 6.09 | 6.15 | 6.03 | 6.09 | 107192 |
| May 15, 2012 | 6.08 | 6.09 | 6.011 | 6.07 | 108542 |
| May 14, 2012 | 6.06 | 6.12 | 6.04 | 6.09 | 82023 |
| May 11, 2012 | 6.07 | 6.170 | 6.07 | 6.13 | 101533 |
| May 10, 2012 | 6.05 | 6.16 | 6.00 | 6.13 | 107671 |
| May 9, 2012 | 5.98 | 6.08 | 5.98 | 6.02 | 101122 |
| May 8, 2012 | 6.00 | 6.10 | 5.96 | 6.06 | 171968 |
| May 7, 2012 | 5.84 | 6.07 | 5.84 | 6.05 | 206022 |
| May 4, 2012 | 5.86 | 5.91 | 5.785 | 5.86 | 240567 |
| May 3, 2012 | 6.15 | 6.19 | 5.79 | 5.90 | 245125 |
| May 2, 2012 | 6.11 | 6.16 | 6.09 | 6.16 | 287877 |
| May 1, 2012 | 6.22 | 6.26 | 6.13 | 6.17 | 233541 |
| April 30, 2012 | 6.36 | 6.41 | 6.22 | 6.23 | 108765 |
| April 27, 2012 | 6.44 | 6.49 | 6.24 | 6.38 | 236219 |
| April 25, 2012 | 6.38 | 6.49 | 6.34 | 6.43 | 154874 |
| April 24, 2012 | 6.10 | 6.31 | 6.085 | 6.31 | 125920 |
| April 23, 2012 | 6.07 | 6.16 | 6.06 | 6.11 | 155877 |
| April 20, 2012 | 6.20 | 6.20 | 6.08 | 6.17 | 122828 |
| April 19, 2012 | 6.11 | 6.23 | 6.08 | 6.10 | 119353 |
| April 18, 2012 | 6.24 | 6.26 | 6.10 | 6.10 | 118636 |
| April 17, 2012 | 6.26 | 6.35 | 6.19 | 6.29 | 106625 |
| April 16, 2012 | 6.14 | 6.21 | 6.02 | 6.20 | 237415 |
| April 13, 2012 | 6.30 | 6.31 | 6.10 | 6.12 | 280694 |
| April 12, 2012 | 6.42 | 6.46 | 6.34 | 6.35 | 124273 |
| April 11, 2012 | 6.47 | 6.52 | 6.36 | 6.42 | 100063 |
| April 10, 2012 | 6.55 | 6.56 | 6.35 | 6.41 | 221351 |
| April 9, 2012 | 6.59 | 6.59 | 6.45 | 6.56 | 153669 |
| April 5, 2012 | 6.73 | 6.75 | 6.692 | 6.70 | 78911 |
| April 4, 2012 | 6.83 | 6.87 | 6.70 | 6.76 | 228032 |
| April 3, 2012 | 6.92 | 6.940 | 6.82 | 6.89 | 239903 |
| April 2, 2012 | 6.82 | 6.92 | 6.81 | 6.92 | 205415 |
| March 30, 2012 | 7.03 | 7.03 | 6.80 | 6.84 | 324726 |
| March 29, 2012 | 7.08 | 7.08 | 6.90 | 6.97 | 126987 |
| March 28, 2012 | 7.24 | 7.28 | 7.08 | 7.13 | 138712 |
| March 27, 2012 | 7.21 | 7.335 | 7.20 | 7.22 | 175498 |
| March 26, 2012 | 7.01 | 7.21 | 7.00 | 7.20 | 187581 |
| March 23, 2012 | 6.77 | 6.77 | 6.77 | 6.77 | 0.00 |
| March 22, 2012 | 6.77 | 6.83 | 6.74 | 6.77 | 267910 |
| March 21, 2012 | 6.93 | 6.93 | 6.93 | 6.93 | 0.00 |
| March 20, 2012 | 7.01 | 7.01 | 6.89 | 6.93 | 157857 |
| March 19, 2012 | 6.96 | 7.169 | 6.94 | 7.06 | 225430 |
| March 16, 2012 | 7.01 | 7.06 | 6.88 | 6.98 | 626551 |
| March 15, 2012 | 6.98 | 7.02 | 6.87 | 6.99 | 208492 |
ENZN News
$ENZN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3FPH
about 53 days ago by MarketBrief
about 53 days ago by MarketBrief
Icahn Capital's George Hebard Named as Director on Enzon Pharma (ENZN) Board
Feb 28, 5:17PM Street Insider
Feb 28, 5:17PM Street Insider
@TER_Intraday nice Fry Pan bottom in $ENZN since early Dec. Thanks for that.
about 123 days ago by 1nvestor
about 123 days ago by 1nvestor
EBR: Watchlist/worksheet/3Trading Ideas: $POT $IACI $ENZN http://stks.co/27m6
about 123 days ago by TER_Intraday
about 123 days ago by TER_Intraday
$ENZN http://stks.co/1VXa Biotech name. Flagging right under the 50MA. Watch the $7.15 level.
about 168 days ago by VexTrades
about 168 days ago by VexTrades
Enzon Presents Data From Phase II PEG-SN38 (EZN-2208) Study in Patients With Metastatic Breast Cancer
Dec 08, 6:15PM Marketwire
Dec 08, 6:15PM Marketwire
$ENZN http://stks.co/1Q88 Long setup for a short term trade. Tight price action in small wedge after recent strong buy volume
about 174 days ago by ToddinFL
about 174 days ago by ToddinFL
$ENZN http://stks.co/1ONJ Heavy short interest may have been taken out last week. Seth Klarman & Carl Icahn own 30% of shares.
about 175 days ago by drdebt
about 175 days ago by drdebt
Enzon Presents Clinical and Preclinical Data on mRNA Antagonists at 2011 AACR-NCI-EORTC Meeting
Nov 12, 1:00PM Marketwire
Nov 12, 1:00PM Marketwire
Enzon COO Ralph Del Campo steps down, CFO Ana I. Stancic promoted to COO
Oct 17, 4:25PM FlyOnTheWall
Oct 17, 4:25PM FlyOnTheWall
Enzon Pharma (ENZN) Promotes CFO Stancic to COO; Forms Special Committee
Oct 17, 4:14PM Street Insider
Oct 17, 4:14PM Street Insider
Enzon Announces Promotion of CFO Ana I. Stancic to COO; Continues to Serve as CFO
Oct 17, 4:14PM Benzinga
Oct 17, 4:14PM Benzinga
Iridian Asset Management Raises Stake in Enzon Pharmaceuticals, Inc. (ENZN) to 11.6%
Oct 06, 1:47PM Street Insider
Oct 06, 1:47PM Street Insider
Enzon $ENZN to Cut Workforce by 48% to Support R&D Activities, Sees Q3 Charge ~$3M
about 249 days ago by Street_Insider
about 249 days ago by Street_Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ENZN | 6.32 | +0.16 | +2.60% | 305.19M |
| DWSN | 24.95 | +0.07 | +0.28% | 197.60M |
| DWRI | None | None | None | |
| DWM | 39.25 | -0.11 | -0.27% | |
| DWCH | 12.06 | -0.17 | -1.39% | 75.25M |
| DWA | 17.85 | +0.13 | +0.73% | 1.500B |
| DW | 26.41 | -0.21 | -0.79% | 587.36M |
| DVY | 54.98 | -0.09 | -0.16% | |
| DVOX | 1.51 | +0.00 | +0.00% | 15.89M |
| DVN | 60.02 | -0.41 | -0.68% | 24.25B |